Oak Ridge National Laboratory researchers used additive manufacturing to build a first-of-its kind smart wall called EMPOWER.
Oak Ridge National Laboratory scientists have discovered a cost-effective way to significantly improve the mechanical performance of common polymer nanocomposite materials.
Oak Ridge National Laboratory researchers have designed and additively manufactured a first-of-its-kind aluminum device that enhances the capture of carbon dioxide emitted from fossil fuel plants and other industrial processes.
Oak Ridge National Laboratory researchers have developed artificial intelligence software for powder bed 3D printers that assesses the quality of parts in real time, without the need for expensive characterization equipment.
Horizon31, LLC has exclusively licensed a novel communication system that allows users to reliably operate unmanned vehicles such as drones from anywhere in the world using only an internet connection.
Combining expertise in physics, applied math and computing, Oak Ridge National Laboratory scientists are expanding the possibilities for simulating electromagnetic fields that underpin phenomena in materials design and telecommunications.
Real-time measurements captured by researchers at ORNL provide missing insight into chemical separations to recover cobalt, a critical raw material used to make batteries and magnets for modern technologies.
ORNL has licensed two additive manufacturing-related technologies that aim to streamline and ramp up production processes to Knoxville-based Magnum Venus Products, Inc., a global manufacturer of fluid movement and product solutions for industrial applications in composites and adhesives.
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.